TRUE TEST PATCH Canada - English - Health Canada

true test patch

mekos laboratories aps - nickel sulfate; wool alcohols; neomycin sulfate; potassium dichromate; benzocaine; dibucaine hydrochloride; tetracaine hydrochloride; amyl cinnamal; isoeugenol; cinnamaldehyde; eugenol; cinnamyl alcohol; hydroxycitronellal; geraniol; oak moss; rosin; epoxy resin; clioquinol; chloroquinaldol; peruvian balsam; ethylenediamine dihydrochloride; cobaltous chloride; p-tert-butylphenol formaldehyde resin; methylparaben; ethyl paraben; propylparaben; butylparaben; benzyl paraben; diphenylguanidine; zinc dibutyldithiocarbamate; n-cyclohexyl-n'-phenyl-para-phenylenediamine; methylchloroisothiazolinone; quaternium-15; mercaptobenzothiazole; p-phenylenediamine; (morpholinothio)benzothiazole; dithiobis (benzothiazole); thimerosal; thiram; bis(1-piperidylthiocarbonyl)disulfide; zinc diethyldithiocarbamate; n-isopropyl-n'-phenyl-para-phenylenediamine; n,n'-diphenyl-para-phenylenediamine; tetramethylthiuram monosulfide; disulfiram; n-cyclohexyl-2-benzothiazolesulfenamide; n-hydroxymethylsuccinimide - patch - 0.16mg; 0.81mg; 0.19mg; 0.019mg; 0.364mg; 0.073mg; 0.073mg; 0.015mg; 0.015mg; 0.034mg; 0.034mg; 0.054mg; 0.054mg; 0.07mg; 0.07mg; 0.69mg; 0.041mg; 0.08mg; 0.08mg; 0.65mg; 0.041mg; 0.016mg; 0.041mg; 0.16mg; 0.16mg; 0.16mg; 0.16mg; 0.16mg; 0.068mg; 0.068mg; 0.025mg; 0.0032mg; 0.081mg; 0.061mg; 0.073mg; 0.02mg; 0.02mg; 0.0065mg; 0.005mg; 0.005mg; 0.068mg; 0.01mg; 0.025mg; 0.005mg; 0.005mg; 0.02mg; 0.15mg - nickel sulfate 0.16mg; wool alcohols 0.81mg; neomycin sulfate 0.19mg; potassium dichromate 0.019mg; benzocaine 0.364mg; dibucaine hydrochloride 0.073mg; tetracaine hydrochloride 0.073mg; amyl cinnamal 0.015mg; isoeugenol 0.015mg; cinnamaldehyde 0.034mg; eugenol 0.034mg; cinnamyl alcohol 0.054mg; hydroxycitronellal 0.054mg; geraniol 0.07mg; oak moss 0.07mg; rosin 0.69mg; epoxy resin 0.041mg; clioquinol 0.08mg; chloroquinaldol 0.08mg; peruvian balsam 0.65mg; ethylenediamine dihydrochloride 0.041mg; cobaltous chloride 0.016mg; p-tert-butylphenol formaldehyde resin 0.041mg; methylparaben 0.16mg; ethyl paraben 0.16mg; propylparaben 0.16mg; butylparaben 0.16mg; benzyl paraben 0.16mg; diphenylguanidine 0.068mg; zinc dibutyldithiocarbamate 0.068mg; n-cyclohexyl-n'-phenyl-para-phenylenediamine 0.025mg; methylchloroisothiazolinone 0.0032mg; quaternium-15 0.081mg; mercaptobenzothiazole 0.061mg; p-phenylenediamine 0.073mg; (morpholinothio)benzothiazole 0.02mg; dithiobis (benzothiazole) 0.02mg; thimerosal 0.0065mg; thiram 0.005mg; bis(1-piperidylthiocarbonyl)disulfide 0.005mg; zinc diethyldithiocarbamate 0.068mg; n-isopropyl-n'-phenyl-para-phenylenediamine 0.01mg; n,n'-diphenyl-para-phenylenediamine 0.025mg; tetramethylthiuram monosulfide 0.005mg; disulfiram 0.005mg; n-cyclohexyl-2-benzothiazolesulfenamide 0.02mg; n-hydroxymethylsuccinimide 0.15mg - allergenic extracts

EKOS EkoSonic Endovascular System Singapore - English - HSA (Health Sciences Authority)

ekos ekosonic endovascular system

boston scientific asia pacific pte. ltd. - cardiovascular - the ekosonic endovascular system is indicated for the:  ultrasound facilitated, controlled and selective infusion of physician-specified fluids, including thrombolytics, into the vasculature for the treatment of pulmonary embolism.  infusion of solutions into the pulmonary arteries.  controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.

Ekosonic MACH4 Endovascular Device  - Ultrasound thrombolysis system pulmonary artery catheter Australia - English - Department of Health (Therapeutic Goods Administration)

ekosonic mach4 endovascular device - ultrasound thrombolysis system pulmonary artery catheter

boston scientific pty ltd - 59223 - ultrasound thrombolysis system pulmonary artery catheter - high frequency low power ultrasound facilitates the delivery of thrombolytics into the pulmonary embolism through an intelligent drug delivery catheter and microsonic device connected to a control unit which deliver the thrombolytics and ultrasound to the treatment site.the control unit generates ultrasonic waves which emanate radially from the treatment zone into and through the blood, thrombus or tissue surrounding the treatment zone with the patients pulmonary embolism. intended for the treatment of pulmonary embolism patients with >/= 50% clot burden in one or both main pulmonary arteries or lobar pulmonary arteries , and evidence of right heart dysfunction based on right heart pressures(mean pulmonary artery pressure >/= 25 mmhg) or echocardiographic evaluation.

EKOS? Endovascular Device - Ultrasound thrombolysis system pulmonary artery catheter Australia - English - Department of Health (Therapeutic Goods Administration)

ekos? endovascular device - ultrasound thrombolysis system pulmonary artery catheter

boston scientific pty ltd - 59223 - ultrasound thrombolysis system pulmonary artery catheter - the system generates ultrasonic energy waves at the treatment zone through the piezoelectric transduction of radio-frequency (rf) energy generated by the control unit. the ultrasound emanates radially from the treatment zone into and through blood, thrombus, or tissue surrounding the treatment zone, within the patient?s vasculature. the ultrasound acts locally to increase the dispersion of the delivered physician specified fluids into the treatment region. the ekos endovascular device is intended to be used with ekos-branded control systems to employ high frequency (2 mhz -3 mhz), low power ultrasound to facilitate the infusion of physician-specified fluids, including procedural fluids and thrombolytics, into the pulmonary and/or peripheral vasculature of adults. it is intended to be used by physicians with knowledge in endovascular interventional procedures. the ekos endovascular system is not intended for use in the neurovasculature. the intended patient population is considered adult patients with symptomatic thrombosis in the pulmonary vessels and/or in the peripheral vasculature such as the iliac and femoral vessels.

JAMP-TACROLIMUS CAPSULE (IMMEDIATE RELEASE) Canada - English - Health Canada

jamp-tacrolimus capsule (immediate release)

jamp pharma corporation - tacrolimus - capsule (immediate release) - 0.5mg - tacrolimus 0.5mg - immunosuppressive agents

JAMP-TACROLIMUS CAPSULE (IMMEDIATE RELEASE) Canada - English - Health Canada

jamp-tacrolimus capsule (immediate release)

jamp pharma corporation - tacrolimus (tacrolimus monohydrate) - capsule (immediate release) - 1mg - tacrolimus (tacrolimus monohydrate) 1mg - immunosuppressive agents

JAMP-TACROLIMUS CAPSULE (IMMEDIATE RELEASE) Canada - English - Health Canada

jamp-tacrolimus capsule (immediate release)

jamp pharma corporation - tacrolimus (tacrolimus monohydrate) - capsule (immediate release) - 5mg - tacrolimus (tacrolimus monohydrate) 5mg - immunosuppressive agents